A leading global pharmaceutical company asked RWS to deliver a machine translation (MT) solution that would deliver efficiency, scalability and return-on-investment for a patient safety/pharmacovigilance (PV) programme.

After careful analysis of the current PV programme, we identified several redundancies and non-cohesive work strategies.

To read more, please download this free white paper.